- Report
- July 2024
- 100 Pages
Global
From €3372EUR$3,750USD£2,890GBP
- Report
- July 2024
- 150 Pages
Global
From €3372EUR$3,750USD£2,890GBP
- Report
- June 2024
- 200 Pages
Global
From €7148EUR$7,950USD£6,128GBP
- Report
- February 2024
- 30 Pages
Global
From €2922EUR$3,250USD£2,505GBP
- Report
- January 2024
- 189 Pages
Global
From €6743EUR$7,500USD£5,781GBP
- Report
- November 2023
- 30 Pages
Global
From €2473EUR$2,750USD£2,120GBP
- Report
- November 2023
- 30 Pages
Global
From €2473EUR$2,750USD£2,120GBP
- Report
- November 2023
- 30 Pages
Global
From €2473EUR$2,750USD£2,120GBP
- Report
- February 2023
- 107 Pages
Global
From €6743EUR$7,500USD£5,781GBP
- Report
- February 2023
- 50 Pages
Global
From €3551EUR$3,950USD£3,045GBP
- Report
- March 2024
- 200 Pages
Global
From €3731EUR$4,150USD£3,199GBP
- Report
- February 2024
- 158 Pages
Global
From €4181EUR$4,650USD£3,584GBP
- Report
- August 2023
- 336 Pages
Global
From €4181EUR$4,650USD£3,584GBP
- Report
- December 2022
- 66 Pages
Global
From €3147EUR$3,500USD£2,698GBP
- Report
- January 2020
- 54 Pages
Global
From €1776EUR$1,975USD£1,522GBP
- Report
- May 2026
- 200 Pages
Canada
From €2508EUR$2,789USD£2,150GBP
- Report
- July 2025
- 350 Pages
Global
From €4450EUR$4,949USD£3,814GBP
- Report
- July 2025
- 200 Pages
India
From €2508EUR$2,789USD£2,150GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2508EUR$2,789USD£2,150GBP
- Report
- June 2025
- 150 Pages
Global
From €2427EUR$2,699USD£2,080GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more